b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29641712</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>04</Month>\n            <Day>24</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1806-4841</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>93</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <MedlineDate>2018 Jan-Feb</MedlineDate>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Anais brasileiros de dermatologia</Title>\n                <ISOAbbreviation>An Bras Dermatol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Panniculitis associated with amyopathic dermatomyositis.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>119-121</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0365-05962018000100119</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1590/abd1806-4841.20186597</ELocationID>\n            <Abstract>\n                <AbstractText>Panniculitis is a rare clinical finding in dermatomyositis, with less than 30 cases reported and there is only one case associated with the amyopathic subtype described in the literature. The present report describes a 49-year-old female patient that one year after being diagnosed with amyopathic dermatomyositis, presented indurated, painful, erythematous to violaceous nodules located on the upper limbs, thighs and gluteal region. Skin biopsy revealed lobular panniculitis with a lymphocytic infiltrate. The patient was treated with prednisone and methotrexate, but remained unresponsive to treatment.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Azevedo</LastName>\n                    <ForeName>Paula de Oliveira</ForeName>\n                    <Initials>PO</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>(Dermatology Service, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Castellen</LastName>\n                    <ForeName>Natalia Roberta</ForeName>\n                    <Initials>NR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>(Dermatology Service, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Salai</LastName>\n                    <ForeName>Ana Fl\xc3\xa1via</ForeName>\n                    <Initials>AF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>(Dermatology Service, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Barbosa</LastName>\n                    <ForeName>Fernanda Santana</ForeName>\n                    <Initials>FS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>(Dermatology Service, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alves</LastName>\n                    <ForeName>C\xc3\xa9lia Ant\xc3\xb4nia Xavier de Moraes</ForeName>\n                    <Initials>CAXM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>(Dermatology Service, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pinto</LastName>\n                    <ForeName>Cl\xc3\xb3vis Antonio Lopes</ForeName>\n                    <Initials>CAL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Faculdade de Medicina de Jundia\xc3\xad (FMJ) - Jundia\xc3\xad (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Pathology Service, Hospital AC Camargo - S\xc3\xa3o Paulo (SP), Brasil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D002363">Case Reports</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Spain</Country>\n            <MedlineTA>An Bras Dermatol</MedlineTA>\n            <NlmUniqueID>0067662</NlmUniqueID>\n            <ISSNLinking>0365-0596</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D003879">Dermatologic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>VB0R961HZT</RegistryNumber>\n                <NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>YL5FZ2Y5U1</RegistryNumber>\n                <NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <SupplMeshList>\n            <SupplMeshName Type="Disease" UI="C538250">Amyopathic dermatomyositis</SupplMeshName>\n        </SupplMeshList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003879" MajorTopicYN="N">Dermatologic Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003882" MajorTopicYN="N">Dermatomyositis</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015434" MajorTopicYN="N">Panniculitis</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2016</Year>\n                <Month>10</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29641712</ArticleId>\n            <ArticleId IdType="pii">S0365-05962018000100119</ArticleId>\n            <ArticleId IdType="doi">10.1590/abd1806-4841.20186597</ArticleId>\n            <ArticleId IdType="pmc">PMC5871377</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Springerplus. 2015 Apr 30;4:201</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25977892</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2009 Jun;28 Suppl 1:S57-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19360363</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 1991 Jun;24(6 Pt 1):959-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1869684</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Dermatol. 2000 Feb;39(2):141-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10692064</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>An Bras Dermatol. 2011 Jan-Feb;86(1):146-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21437539</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Isr Med Assoc J. 2007 Jun;9(6):492-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17642406</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'